Short Description
Quantifies α-amylase activity using a colorimetric method.
Development Stage
Research-Grade Metabolic Assay Development
Description
The OXPHOSight™ α-Amylase Assay Kit provides a robust solution for evaluating pancreatic function and starch metabolism in pre-clinical studies. This high-throughput compatible system is essential for screening anti-diabetic drug candidates that target carbohydrate digestion, offering precise kinetic data to optimize dosing strategies. By enabling the rapid quantification of enzyme activity in diverse biological samples, it supports rigorous efficacy testing and safety profiling in pharmaceutical development.
Features
High-throughput compatible format ideal for large-scale inhibitor screening; Linear detection range facilitates precise kinetic studies in drug interaction assays.
Process Relevance
Metabolic Disease Drug Screening
Application Stage
Hit-to-Lead Screening
Applications
Suitable for analyzing amylase levels in blood, saliva, urine, and agricultural samples.
Qualified With
Internal performance validation using reference standards under defined assay conditions.
Detection Method
Absorbance at 585 nm
Sample Type
Blood, saliva, urine, agriculture samples
Research Areas
Gastroenterology; Diabetes & Obesity
Datasheet